Skip to main content
Erschienen in:

07.05.2018 | Original Article

Microvascular diabetes complications in a specialist young adult diabetes service

verfasst von: Audrey Melvin, Lynn Redahan, Mensud Hatunic, Siobhán E McQuaid

Erschienen in: Irish Journal of Medical Science (1971 -) | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Background and aims

The provision of medical care to young adults with type 1 diabetes mellitus is challenging. The aim of this study was to determine the rates of microvascular complications and their progression among patients with type 1 diabetes mellitus attending a specialist young adult diabetes service in Ireland.

Methods

A retrospective review of 62 (male 56.5%) patients with type 1 diabetes mellitus attending the young adult diabetes service at our institution was undertaken. Data was recorded across two time points, clinic registration and at 5 years following initial contact.

Results

The mean ± SD age at first attendance was 17.4 ± 2.0 years. Mean ± SD duration of diabetes was 6.3 ± 3.9 years with most patients treated using multiple daily insulin injections (75.8%). diabetic retinopathy rate at first attendance was 17.7% and after 5 years was 37.1% (p = 0.003). The majority of cases were background retinopathy. The prevalence of diabetic kidney disease was 6.4% and this remained unchanged at follow-up. Mean ± SD HbA1c improved from 76.1 ± 22.4 mmol/mol (9.1 ± 4.2%) to 69.1 ± 14.9 mmol/mol (8.5 ± 3.5%), p = 0.044. Duration of diabetes was the only clinical variable associated with retinopathy risk at 5 years on multiple regression analysis (p = 0.037).

Conclusions

Diabetic retinopathy is prevalent in young adults with type 1 diabetes attending specialist secondary care diabetes services. Duration of diabetes was the strongest determinant of retinopathy risk.
Literatur
1.
Zurück zum Zitat Dahlquist GG, Nystrom L, Patterson CC (2011) Swedish childhood diabetes study G, diabetes incidence in Sweden study G. Incidence of type 1 diabetes in Sweden among individuals aged 0-34 years, 1983-2007: an analysis of time trends. Diabetes Care 34(8):1754–1759CrossRefPubMedPubMedCentral Dahlquist GG, Nystrom L, Patterson CC (2011) Swedish childhood diabetes study G, diabetes incidence in Sweden study G. Incidence of type 1 diabetes in Sweden among individuals aged 0-34 years, 1983-2007: an analysis of time trends. Diabetes Care 34(8):1754–1759CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltesz G (2009) Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet (London, England) 373(9680):2027–2033CrossRef Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltesz G (2009) Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet (London, England) 373(9680):2027–2033CrossRef
3.
Zurück zum Zitat Patterson CC, Gyurus E, Rosenbauer J, Cinek O, Neu A, Schober E et al (2012) Trends in childhood type 1 diabetes incidence in Europe during 1989-2008: evidence of non-uniformity over time in rates of increase. Diabetologia 55(8):2142–2147CrossRefPubMed Patterson CC, Gyurus E, Rosenbauer J, Cinek O, Neu A, Schober E et al (2012) Trends in childhood type 1 diabetes incidence in Europe during 1989-2008: evidence of non-uniformity over time in rates of increase. Diabetologia 55(8):2142–2147CrossRefPubMed
4.
Zurück zum Zitat Roche EF, McKenna AM, Ryder KJ, Brennan AA, O'Regan M, Hoey HM (2016) Is the incidence of type 1 diabetes in children and adolescents stabilising? The first 6 years of a National Register. Eur J Pediatr 175(12):1913–1919CrossRefPubMed Roche EF, McKenna AM, Ryder KJ, Brennan AA, O'Regan M, Hoey HM (2016) Is the incidence of type 1 diabetes in children and adolescents stabilising? The first 6 years of a National Register. Eur J Pediatr 175(12):1913–1919CrossRefPubMed
5.
Zurück zum Zitat Arnett JJ (2000) Emerging adulthood. A theory of development from the late teens through the twenties. Am Psychol 55(5):469–480CrossRef Arnett JJ (2000) Emerging adulthood. A theory of development from the late teens through the twenties. Am Psychol 55(5):469–480CrossRef
6.
Zurück zum Zitat Peters A, Laffel L, American Diabetes Association Transitions Working G (2011) Diabetes care for emerging adults: recommendations for transition from pediatric to adult diabetes care systems: a position statement of the American Diabetes Association, with representation by the American College of Osteopathic Family Physicians, the American Academy of Pediatrics, the American Association of Clinical Endocrinologists, the American Osteopathic Association, the Centers for Disease Control and Prevention, Children with iabetes, The Endocrine Society, the International Society for Pediatric and Adolescent Diabetes, Juvenile Diabetes Research Foundation International, the National Diabetes Education Program, and the Pediatric Endocrine Society (formerly Lawson Wilkins Pediatric Endocrine Society). Diabetes Care 34(11):2477–2485CrossRefPubMedPubMedCentral Peters A, Laffel L, American Diabetes Association Transitions Working G (2011) Diabetes care for emerging adults: recommendations for transition from pediatric to adult diabetes care systems: a position statement of the American Diabetes Association, with representation by the American College of Osteopathic Family Physicians, the American Academy of Pediatrics, the American Association of Clinical Endocrinologists, the American Osteopathic Association, the Centers for Disease Control and Prevention, Children with iabetes, The Endocrine Society, the International Society for Pediatric and Adolescent Diabetes, Juvenile Diabetes Research Foundation International, the National Diabetes Education Program, and the Pediatric Endocrine Society (formerly Lawson Wilkins Pediatric Endocrine Society). Diabetes Care 34(11):2477–2485CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Livingstone SJ, Looker HC, Hothersall EJ, Wild SH, Lindsay RS, Chalmers J, Cleland S, Leese GP, McKnight J, Morris AD, Pearson DWM, Peden NR, Petrie JR, Philip S, Sattar N, Sullivan F, Colhoun HM (2012) Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study. PLoS Med 9(10):e1001321CrossRefPubMedPubMedCentral Livingstone SJ, Looker HC, Hothersall EJ, Wild SH, Lindsay RS, Chalmers J, Cleland S, Leese GP, McKnight J, Morris AD, Pearson DWM, Peden NR, Petrie JR, Philip S, Sattar N, Sullivan F, Colhoun HM (2012) Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study. PLoS Med 9(10):e1001321CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Livingstone SJ, Levin D, Looker HC, Lindsay RS, Wild SH, Joss N, Leese G, Leslie P, McCrimmon R, Metcalfe W, McKnight J, Morris AD, Pearson DW, Petrie JR, Philip S, Sattar NA, Traynor JP, Colhoun HM, Scottish Diabetes Research Network epidemiology group, Scottish Renal Registry (2015) Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010. JAMA 313(1):37–44CrossRefPubMedPubMedCentral Livingstone SJ, Levin D, Looker HC, Lindsay RS, Wild SH, Joss N, Leese G, Leslie P, McCrimmon R, Metcalfe W, McKnight J, Morris AD, Pearson DW, Petrie JR, Philip S, Sattar NA, Traynor JP, Colhoun HM, Scottish Diabetes Research Network epidemiology group, Scottish Renal Registry (2015) Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010. JAMA 313(1):37–44CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat American Diabetes Association (2017) Microvascular complications and foot care. Diabetes Care 40(Suppl 1):S88–S98CrossRef American Diabetes Association (2017) Microvascular complications and foot care. Diabetes Care 40(Suppl 1):S88–S98CrossRef
11.
Zurück zum Zitat Johnson B, Elliott J, Scott A, Heller S, Eiser C (2014) Medical and psychological outcomes for young adults with type 1 diabetes: no improvement despite recent advances in diabetes care. Diabet Med 31(2):227–231CrossRefPubMed Johnson B, Elliott J, Scott A, Heller S, Eiser C (2014) Medical and psychological outcomes for young adults with type 1 diabetes: no improvement despite recent advances in diabetes care. Diabet Med 31(2):227–231CrossRefPubMed
12.
Zurück zum Zitat Levy-Shraga Y, Elisha N, Ben-Ami M, Boyko V, Lerner-Geva L, Ziv T, Konvalina N, Cohen O, Pinhas-Hamiel O (2016) Glycemic control and clinic attendance of emerging adults with type 1 diabetes at a transition care clinic. Acta Diabetol 53(1):27–33CrossRefPubMed Levy-Shraga Y, Elisha N, Ben-Ami M, Boyko V, Lerner-Geva L, Ziv T, Konvalina N, Cohen O, Pinhas-Hamiel O (2016) Glycemic control and clinic attendance of emerging adults with type 1 diabetes at a transition care clinic. Acta Diabetol 53(1):27–33CrossRefPubMed
13.
Zurück zum Zitat Hammes HP, Kerner W, Hofer S, Kordonouri O, Raile K, Holl RW et al (2011) Diabetic retinopathy in type 1 diabetes-a contemporary analysis of 8,784 patients. Diabetologia 54(8):1977–1984CrossRefPubMed Hammes HP, Kerner W, Hofer S, Kordonouri O, Raile K, Holl RW et al (2011) Diabetic retinopathy in type 1 diabetes-a contemporary analysis of 8,784 patients. Diabetologia 54(8):1977–1984CrossRefPubMed
14.
Zurück zum Zitat Carlsen S, Skrivarhaug T, Thue G, Cooper JG, Goransson L, Lovaas K et al (2016) Glycemic control and complications in patients with type 1 diabetes - a registry-based longitudinal study of adolescents and young adults. Pediatr Diabetes Carlsen S, Skrivarhaug T, Thue G, Cooper JG, Goransson L, Lovaas K et al (2016) Glycemic control and complications in patients with type 1 diabetes - a registry-based longitudinal study of adolescents and young adults. Pediatr Diabetes
15.
Zurück zum Zitat White NH, Sun W, Cleary PA, Tamborlane WV, Danis RP, Hainsworth DP, Davis MD, for the DCCT-EDIC Research Group (2010) Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents. Diabetes 59(5):1244–1253CrossRefPubMedPubMedCentral White NH, Sun W, Cleary PA, Tamborlane WV, Danis RP, Hainsworth DP, Davis MD, for the DCCT-EDIC Research Group (2010) Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents. Diabetes 59(5):1244–1253CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat American Diabetes Association (2017) Children and adolescents. Diabetes Care 40(Suppl 1):S105–S113CrossRef American Diabetes Association (2017) Children and adolescents. Diabetes Care 40(Suppl 1):S105–S113CrossRef
17.
Zurück zum Zitat American Diabetes Association (2017) Glycemic Targets. Diabetes Care 40(Suppl 1):S48–S56 American Diabetes Association (2017) Glycemic Targets. Diabetes Care 40(Suppl 1):S48–S56
18.
Zurück zum Zitat Casey R, O'Hara MC, Cunningham A, Wall D, Geoghegan R, Hynes L, McGuire B, Gately M, Bell M, Dinneen SF (2014) Young adult type 1 diabetes care in the West of Ireland: an audit of hospital practice. QJM 107(11):903–908CrossRefPubMed Casey R, O'Hara MC, Cunningham A, Wall D, Geoghegan R, Hynes L, McGuire B, Gately M, Bell M, Dinneen SF (2014) Young adult type 1 diabetes care in the West of Ireland: an audit of hospital practice. QJM 107(11):903–908CrossRefPubMed
19.
Zurück zum Zitat Bryden S, Dunger DB, Mayou RA, Peveler RC, Neil HAW (2003) Poor prognosis of young adults with type 1 diabetes. Diabetes Care 26:1052–1057CrossRefPubMed Bryden S, Dunger DB, Mayou RA, Peveler RC, Neil HAW (2003) Poor prognosis of young adults with type 1 diabetes. Diabetes Care 26:1052–1057CrossRefPubMed
20.
Zurück zum Zitat Nordwall M., Abrahamsson M., Dhir M., Fredrikson M., Ludvigsson J., H.J. A. Impact of HbA1c , followed from onset of type 1 diabetes, on the development of severe retinopathy and nephropathy: the VISS study (vascular diabetic complications in Southeast Sweden). Diabetes Care 2015;38:308–315 Nordwall M., Abrahamsson M., Dhir M., Fredrikson M., Ludvigsson J., H.J. A. Impact of HbA1c , followed from onset of type 1 diabetes, on the development of severe retinopathy and nephropathy: the VISS study (vascular diabetic complications in Southeast Sweden). Diabetes Care 2015;38:308–315
21.
Zurück zum Zitat DuBose SN, Hermann JM, Tamborlane WV, Beck RW, Dost A, DiMeglio LA et al (2015) Obesity in Youth with Type 1 Diabetes in Germany, Austria, and the United States. J Pediatr 167(3):627–32 e1–4CrossRefPubMed DuBose SN, Hermann JM, Tamborlane WV, Beck RW, Dost A, DiMeglio LA et al (2015) Obesity in Youth with Type 1 Diabetes in Germany, Austria, and the United States. J Pediatr 167(3):627–32 e1–4CrossRefPubMed
22.
Zurück zum Zitat Homma TK, Endo CM, Saruhashi T, Mori AP, Noronha RM, Monte O et al (2015) Dyslipidemia in young patients with type 1 diabetes mellitus. Arch Endocrinol Metab 59(3):215–219CrossRefPubMed Homma TK, Endo CM, Saruhashi T, Mori AP, Noronha RM, Monte O et al (2015) Dyslipidemia in young patients with type 1 diabetes mellitus. Arch Endocrinol Metab 59(3):215–219CrossRefPubMed
23.
Zurück zum Zitat Jacobson AM, Hauser ST, Willett JB, Wolfsdorf JI, Dvorak R, Herman L, Groot MD (1997) Psychological adjustment to IDDM: 10-year follow-up of an onset cohort of child and adolescent patients. Diabetes Care 20(5):811–818CrossRefPubMed Jacobson AM, Hauser ST, Willett JB, Wolfsdorf JI, Dvorak R, Herman L, Groot MD (1997) Psychological adjustment to IDDM: 10-year follow-up of an onset cohort of child and adolescent patients. Diabetes Care 20(5):811–818CrossRefPubMed
24.
Zurück zum Zitat Wisting L, Bang L, Skrivarhaug T, Dahl-Jorgensen K, Ro O (2015) Adolescents with type 1 diabetes--the impact of gender, age, and health-related functioning on eating disorder psychopathology. PLoS One 10(11):e0141386CrossRefPubMedPubMedCentral Wisting L, Bang L, Skrivarhaug T, Dahl-Jorgensen K, Ro O (2015) Adolescents with type 1 diabetes--the impact of gender, age, and health-related functioning on eating disorder psychopathology. PLoS One 10(11):e0141386CrossRefPubMedPubMedCentral
Metadaten
Titel
Microvascular diabetes complications in a specialist young adult diabetes service
verfasst von
Audrey Melvin
Lynn Redahan
Mensud Hatunic
Siobhán E McQuaid
Publikationsdatum
07.05.2018
Verlag
Springer London
Erschienen in
Irish Journal of Medical Science (1971 -) / Ausgabe 1/2019
Print ISSN: 0021-1265
Elektronische ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-018-1827-9

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

CDK4/6-Inhibitoren bei Brustkrebs in die Zweitlinie aufschieben?

Ergebnisse einer Phase-III-Studie sprechen dafür, dass die Behandlung mit CDK4/6-Inhibitoren bei fortgeschrittenem HR-positivem, HER2-negativem Brustkrebs auch auf die Zweitlinie verschoben werden könnte, ohne die onkologischen Ergebnisse zu kompromittieren.

Inhalative Steroide bei COPD nicht kardioprotektiv

  • 10.01.2025
  • COPD
  • Nachrichten

Ob inhalative Kortikosteroide (ICS) COPD-Kranke außer vor akuten Exazerbationen auch vor kardiovaskulären Komplikationen schützen können, ist unklar. Eine bevölkerungsbasierte Studie aus England spricht nicht dafür.

Kaffeegenuss sicher bei Vorhofflimmern

Menschen mit Vorhofflimmern fürchten oft, Kaffee könnte schlecht für ihr Herz sein. Solche Ängste sind offenbar unbegründet: Zwei Schweizer Untersuchungen deuten sogar auf eine reduzierte Rate von kardiovaskulären Ereignissen unter Kaffeetrinkern.

Cannabisextrakt verbessert Antiemese bei Chemotherapie

Sprechen Krebskranke auf die übliche Antiemese während einer Chemotherapie nicht ausreichend an, lohnt sich möglicherweise eine Behandlung mit Cannabisextrakt. In einer Phase-2/3-Studie ließ sich die antiemetische Response mit einem solchen Extrakt erheblich verbessern.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.